161 related articles for article (PubMed ID: 19057341)
1. Colon cancer screening: recommendations and barriers to patient participation.
Peters DP
Nurse Pract; 2008 Dec; 33(12):14-20; quiz 21. PubMed ID: 19057341
[No Abstract] [Full Text] [Related]
2. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
3. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Parra-Blanco A; Jiménez-Sosa A
Cancer Epidemiol; 2009 Oct; 33(3-4):216-22. PubMed ID: 19747893
[TBL] [Abstract][Full Text] [Related]
4. [Colorectal cancer screening. Where are we?].
Benhaberou-Brun D
Perspect Infirm; 2013; 10(3):52-5. PubMed ID: 23710531
[No Abstract] [Full Text] [Related]
5. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
6. Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?
Marshall KG
CMAJ; 2000 Sep; 163(5):545-6; discussion 547. PubMed ID: 11006766
[No Abstract] [Full Text] [Related]
7. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
8. [Participation and medical follow-up in screening of colorectal cancer in France within the SU.VI.MAX study].
Cailhol J; Czernichow S; Mennen L; Boutron-Ruault MC; Zarebska M; Franchisseur C; Preziosi P; Galan P; Hercberg S
Rev Epidemiol Sante Publique; 2002 Jun; 50(3):321-3. PubMed ID: 12122348
[No Abstract] [Full Text] [Related]
9. [Screening colonoscopy for early detection of intestinal cancer].
Mader U
Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
[No Abstract] [Full Text] [Related]
10. [Colorectal cancer screening should be evaluated in Swedish studies].
Blom J
Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
[No Abstract] [Full Text] [Related]
11. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
12. Evidence, efficacy and effectiveness of screening for colorectal cancer with faecal tests.
Faivre J; Lepage C
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S17-9. PubMed ID: 18368633
[No Abstract] [Full Text] [Related]
13. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
Jansen JB; van Rossum LG; Laheij RJ
Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
[TBL] [Abstract][Full Text] [Related]
14. Colon cancer screening and surveillance controversies.
Lieberman D
Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
Saito H
J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
[TBL] [Abstract][Full Text] [Related]
16. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
[No Abstract] [Full Text] [Related]
18. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Communication.
Austoker J; Giordano L; Hewitson P; Villain P;
Endoscopy; 2012 Sep; 44 Suppl 3():SE164-85. PubMed ID: 23012120
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening in Scotland.
Steele RJ
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
[No Abstract] [Full Text] [Related]
20. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
Nash GF
Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
